
BioPlanta becomes BIONCaRT — bm|t, TGFS, private investors and founders jointly invest a seven-figure sum to conduct a clinical trial
bm|t, TGFS, private investors and the founder invest a seven-figure sum in BIONCaRT GmbH (formerly BioPlanta GmbH) in a seed financing round.